Skip to main content
Lotus Pharm logo

Lotus Pharm — Investor Relations & Filings

Ticker · 1795 ISIN · TW0001795003 LEI · 984500BEECDBC04KP716 TW Manufacturing
Open in API
Filings indexed 2,730 across all filing types
Latest filing 2024-05-09 Interim / Quarterly Rep…
Country TW Taiwan
Listing TW 1795

About Lotus Pharm

http://www.lotuspharm.com.tw

Lotus Pharmaceutical Co., Ltd. is a global specialty organization focused on the development, manufacturing, and commercialization of high-barrier generic and specialty medicines. The company specializes in complex generics, with a primary focus on oncology, immunology, and addiction treatment. Its portfolio includes technically demanding products such as Lenalidomide, Suboxone, Nintedanib, and Vinorelbine, as well as an advancing pipeline of biosimilars and 505(b)(2) oncology candidates. Utilizing an integrated R&D and manufacturing platform, the company executes a "2x2" growth strategy centered on dual market expansion and product diversification. Its commercial footprint spans over 90 markets globally, maintaining a strong presence in the Asia-Pacific region and the United States. The company prioritizes high technical entry barriers and cost-effective therapeutic solutions to improve global patient access to essential medications.

Recent filings

Filing Released Lang Actions
113年第1季權益變動表
Interim / Quarterly Report Classification · 95% confidence The document contains detailed financial tables showing changes in equity for the first quarter of the fiscal year 2024 (民國113年第1季) and the same period last year. It includes line items such as common stock, capital surplus, legal surplus reserve, special surplus reserve, undistributed earnings, retained earnings, and other equity components. The presence of detailed financial data for a quarterly period indicates this is a financial report for a period shorter than a full fiscal year. The document length is 3940 characters, which is relatively short but contains substantive financial data, not just an announcement or a certification. Therefore, it fits the definition of an Interim / Quarterly Report (IR). Q1 2024
2024-05-09 Chinese
113年第1季現金流量表
Interim / Quarterly Report Classification · 95% confidence The document contains a consolidated cash flow statement for the first quarter of the 113th year (which corresponds to 2024) and compares it with the same period in the previous year. It includes detailed financial data such as net income before tax, depreciation, amortization, changes in assets and liabilities, and cash flows from operating, investing, and financing activities. The presence of actual financial statements and substantive financial data for a quarterly period indicates this is a comprehensive interim financial report. The document length is 2760 characters, which is relatively short but contains detailed financial tables, not just an announcement or a certification. Therefore, it fits the definition of an Interim / Quarterly Report (IR). Q1 2024
2024-05-09 Chinese
113年第1季綜合損益表
Interim / Quarterly Report Classification · 95% confidence The document contains a consolidated comprehensive income statement for the first quarter of the fiscal year 113 (which corresponds to 2024 in the Gregorian calendar). It includes detailed financial data such as revenue, costs, expenses, net profit, and earnings per share for the quarter ending March 31, 2024, compared to the same period in the previous year. The presence of actual financial statements and substantive financial data for a period shorter than a full fiscal year indicates this is an Interim / Quarterly Report. The document length is 2287 characters, which is sufficient to contain financial data but not a full annual report. There is no indication that this is merely an announcement or a certification. Therefore, the correct classification is Interim / Quarterly Report (IR). Q1 2024
2024-05-09 Chinese
113年第1季資產負債表
Interim / Quarterly Report Classification · 95% confidence The document contains a consolidated balance sheet with detailed financial data for multiple periods, including specific asset, liability, and equity line items. It is presented in a structured tabular format with monetary amounts and percentages, indicating substantive financial information. The document references the fiscal period as the first quarter of the 113th year (likely Taiwanese calendar year 2024 Q1). The length is 4402 characters, which is sufficient to contain actual financial data rather than just an announcement. There is no indication that this is a certification, announcement, or summary. The content matches the characteristics of an Interim / Quarterly Report (IR), as it provides comprehensive financial statements for a period shorter than a full fiscal year. Q1 2024
2024-05-09 Chinese
公告本公司董事會決議通過113年第一季財務報告
Interim / Quarterly Report Classification · 95% confidence The document is a formal announcement from the company (美時) regarding the board of directors' approval of the first quarter financial report for the period 113/01/01 to 113/03/31 (which corresponds to the first quarter). It includes detailed financial figures such as revenue, gross profit, operating profit, net profit, earnings per share, total assets, liabilities, and equity as of the period end. The document is 919 characters long, which is relatively short but contains substantive financial data and analysis for a quarterly period. It is not merely an announcement that a report is available, nor is it a certification or a brief summary. Therefore, it fits the definition of an Interim / Quarterly Report (IR). Q1 2024
2024-05-09 Chinese
113年05月僑外投資持股
Major Shareholding Notification Classification · 95% confidence The document is a statistical table showing the shareholding situation of overseas and mainland China investors, including detailed numbers of shares held before and after certain dates, and explanations of differences. It includes data on foreign and mainland investors' holdings, stock codes, and share counts. There is no indication of a report or announcement of a meeting, voting results, financial results, or management changes. The document is a regulatory disclosure of shareholding information, specifically about major shareholding by foreign and mainland investors. This fits the definition of Major Shareholding Notification (MRQ). The document length is short and it is a direct disclosure, not an announcement of a report or certification. Therefore, the classification is MRQ with high confidence.
2024-05-07 Chinese

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.